Biotricity, Inc. (BTCY)

NASDAQ: BTCY · IEX Real-Time Price · USD
-0.009 (-1.05%)
At close: Nov 28, 2023, 3:11 PM
-0.001 (-0.13%)
After-hours: Nov 28, 2023, 5:54 PM EST

Company Description

Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States.

The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses.

It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components.

The company is based in Redwood City, California.

Biotricity, Inc.
Biotricity logo
Country United States
Industry Medical Devices
Sector Healthcare
Employees 55
CEO Dr. Waqaas Al-Siddiq Ph.D.

Contact Details

203 Redwood Parkway, Suite 600
Redwood City, California 94065
United States
Phone (650) 832-1626

Stock Details

Ticker Symbol BTCY
Exchange NASDAQ
Fiscal Year April - March
Reporting Currency USD
CIK Code 0001630113
CUSIP Number 09074H104
ISIN Number US09074H1041
Employer ID 47-2548273
SIC Code 3841

Key Executives

Name Position
Dr. Waqaas Al-Siddiq Ph.D. Founder, President, Chief Executive Officer and Chairman
S. John Ayanoglou Chief Financial Officer
Dr. George N. Nikopoulos Director of Business Development
Amir Ali Chief Development Officer

Latest SEC Filings

Date Type Title
Nov 14, 2023 10-Q Quarterly Report
Nov 6, 2023 8-K Current Report
Sep 20, 2023 8-K Current Report
Sep 19, 2023 424B5 Filing
Aug 17, 2023 8-K Current Report
Aug 14, 2023 10-Q Quarterly Report
Aug 4, 2023 8-K Current Report
Jul 21, 2023 424B3 Prospectus
Jul 20, 2023 8-K Current Report
Jul 5, 2023 8-K Current Report